Skip to Content

Sawai Pharmaceutical Co Ltd SWPIF

Rating as of

Morningstar’s Analysis

Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Sawai Pharmaceutical Co Ltd is a Japan-based pharmaceutical company. It manufactures and sells, imports, and exports pharmaceutical products. The company offers prescription drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, syrups and others in the therapeutic areas of cardiovascular, gastro-intestinal, chemotherapeutics, vitamins, anti-cancer and others. The group serves various sectors such as hospitals, general practitioners, and dispensing pharmacies.

5-2-30, Miyahara, Yodogawa-Ku
Osaka, 532-0003, Japan
T +81 661055711
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2020
Fiscal Year End Mar 31, 2020
Stock Type
Employees 3,432